Provided by Tiger Fintech (Singapore) Pte. Ltd.

AC Immune SA

1.73
+0.03001.76%
Post-market: 1.800.0700+4.05%19:48 EDT
Volume:211.40K
Turnover:355.52K
Market Cap:171.17M
PE:-3.07
High:1.76
Open:1.70
Low:1.55
Close:1.70
Loading ...

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires Live
·
15 Nov 2024

AC Immune Sa Shares up 8.4% After Interim Mid-Stage Data for Parkinson's Disease Therapy

THOMSON REUTERS
·
14 Nov 2024

AC Immune Shares Gain Following Positive Clinical Results of Potential Parkinson's Treatment

MT Newswires Live
·
14 Nov 2024

AC Immune Shares up 9% Premarket After Interim Mid-Stage Data for Parkinson's Disease Therapy

THOMSON REUTERS
·
14 Nov 2024

BUZZ-AC Immune rises on interim mid-stage data for Parkinson's therapy

Reuters
·
14 Nov 2024

BRIEF-AC Immune Reports Positive Interim Results From Phase 2 Trial Of ACI-7104.056

Reuters
·
14 Nov 2024

AC Immune Reports Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

THOMSON REUTERS
·
14 Nov 2024

AC Immune Sa - 100% of Patients Respond to ACI-7104.056

THOMSON REUTERS
·
14 Nov 2024

AC Immune Sa - ACI-7104.056 Well Tolerated With No Clinically Relevant Safety Issues

THOMSON REUTERS
·
14 Nov 2024

AC Immune Sa - May Initiate Part 2 of Vacsyn With up to 150 Patients

THOMSON REUTERS
·
14 Nov 2024

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

GlobeNewswire
·
14 Nov 2024

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

GlobeNewswire
·
13 Nov 2024

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Simply Wall St.
·
09 Nov 2024

AC Immune Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Nov 2024

AC Immune SA reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
06 Nov 2024

AC Immune Q3 EPS $0.06 Beats $(0.23) Estimate, Sales $29.44M Beat $1.74M Estimate

Benzinga
·
05 Nov 2024

AC Immune: Q3 Earnings Snapshot

Associated Press Finance
·
05 Nov 2024

AC Immune Sa: Qtrly EPS CHF 0.05

THOMSON REUTERS
·
05 Nov 2024

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
05 Nov 2024

AC Immune Q3 Operating Expenses CHF -18.216 Million

THOMSON REUTERS
·
05 Nov 2024